tiprankstipranks
Trending News
More News >
Mannkind Corp. (MNKD)
NASDAQ:MNKD
US Market
Advertisement

MannKind (MNKD) Stock Forecast & Price Target

Compare
2,010 Followers
See the Price Targets and Ratings of:

MNKD Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
MannKind
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MNKD Stock 12 Month Forecast

Average Price Target

$9.21
▲(71.19% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for MannKind in the last 3 months. The average price target is $9.21 with a high forecast of $11.00 and a low forecast of $7.50. The average price target represents a 71.19% change from the last price of $5.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","7":"$7","12":"$12","4.5":"$4.5","9.5":"$9.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.5,7,9.5,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.59,6.006153846153846,6.422307692307692,6.838461538461538,7.254615384615384,7.670769230769231,8.086923076923076,8.503076923076923,8.919230769230769,9.335384615384616,9.751538461538463,10.167692307692308,10.583846153846153,{"y":11,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.59,5.868461538461538,6.146923076923077,6.4253846153846155,6.703846153846154,6.9823076923076925,7.260769230769231,7.53923076923077,7.817692307692308,8.096153846153847,8.374615384615385,8.653076923076924,8.931538461538462,{"y":9.21,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.59,5.736923076923077,5.883846153846154,6.030769230769231,6.177692307692308,6.3246153846153845,6.4715384615384615,6.618461538461538,6.765384615384615,6.912307692307692,7.059230769230769,7.206153846153846,7.353076923076923,{"y":7.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.17,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.59,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.43,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.79,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.34,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.59,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$11.00Average Price Target$9.21Lowest Price Target$7.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MNKD
Unknown Analyst
Truist Financial
Not Ranked
Truist Financial
$9
Buy
67.29%
Upside
Initiated
11/24/25
MannKind (MNKD) Has a New Rating from Truist Financial
Wells Fargo Analyst forecast on MNKD
Wells Fargo
Wells Fargo
$10$8
Buy
48.70%
Upside
Reiterated
11/11/25
Wells Fargo Reaffirms Their Buy Rating on MannKind (MNKD)
Oppenheimer
$15$10
Buy
85.87%
Upside
Reiterated
11/10/25
Oppenheimer Sticks to Its Buy Rating for MannKind (MNKD)
RBC Capital Analyst forecast on MNKD
RBC Capital
RBC Capital
$8$7.5
Buy
39.41%
Upside
Reiterated
11/10/25
RBC Capital Sticks to Their Buy Rating for MannKind (MNKD)
H.C. Wainwright Analyst forecast on MNKD
H.C. Wainwright
H.C. Wainwright
$11
Buy
104.46%
Upside
Reiterated
11/10/25
MannKind's Resilience and Growth Potential: A Buy Rating Amid Setbacks and OpportunitiesValuation and Risks. We base our valuation and 12-month price target of $11 on our discounted cash flow model. We use a 10.2% weighted average cost of capital (WACC), and a 13.0x exit multiple on our 2031 estimates. Our model has been updated to reflect the close of the scPharmaceuticals acquisition. We include pipeline value for 40% probability of success assumption for 30% probability of success assumption for MNKD-201. Our model remains MNKD standalone, and does not as yet incorporate SCPH.
Wedbush Analyst forecast on MNKD
Wedbush
Wedbush
$11$10
Buy
85.87%
Upside
Reiterated
11/10/25
MannKind's Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
Leerink Partners Analyst forecast on MNKD
Leerink Partners
Leerink Partners
$7$9
Buy
67.29%
Upside
Initiated
10/10/25
MannKind (MNKD) Receives a Buy from Leerink PartnersLeerink Partners analyst Faisal A. Khurshid resumes coverage on MannKind (NASDAQ: MNKD) with a Outperform rating and a price target of $9.00.
Mizuho Securities Analyst forecast on MNKD
Mizuho Securities
Mizuho Securities
$12$10
Buy
85.87%
Upside
Reiterated
08/07/25
Mizuho Securities Remains a Buy on MannKind (MNKD)
Cantor Fitzgerald Analyst forecast on MNKD
Cantor Fitzgerald
Cantor Fitzgerald
$9
Buy
67.29%
Upside
Reiterated
03/20/25
MannKind (MNKD) Gets a Buy from Cantor Fitzgerald
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MNKD
Unknown Analyst
Truist Financial
Not Ranked
Truist Financial
$9
Buy
67.29%
Upside
Initiated
11/24/25
MannKind (MNKD) Has a New Rating from Truist Financial
Wells Fargo Analyst forecast on MNKD
Wells Fargo
Wells Fargo
$10$8
Buy
48.70%
Upside
Reiterated
11/11/25
Wells Fargo Reaffirms Their Buy Rating on MannKind (MNKD)
Oppenheimer
$15$10
Buy
85.87%
Upside
Reiterated
11/10/25
Oppenheimer Sticks to Its Buy Rating for MannKind (MNKD)
RBC Capital Analyst forecast on MNKD
RBC Capital
RBC Capital
$8$7.5
Buy
39.41%
Upside
Reiterated
11/10/25
RBC Capital Sticks to Their Buy Rating for MannKind (MNKD)
H.C. Wainwright Analyst forecast on MNKD
H.C. Wainwright
H.C. Wainwright
$11
Buy
104.46%
Upside
Reiterated
11/10/25
MannKind's Resilience and Growth Potential: A Buy Rating Amid Setbacks and OpportunitiesValuation and Risks. We base our valuation and 12-month price target of $11 on our discounted cash flow model. We use a 10.2% weighted average cost of capital (WACC), and a 13.0x exit multiple on our 2031 estimates. Our model has been updated to reflect the close of the scPharmaceuticals acquisition. We include pipeline value for 40% probability of success assumption for 30% probability of success assumption for MNKD-201. Our model remains MNKD standalone, and does not as yet incorporate SCPH.
Wedbush Analyst forecast on MNKD
Wedbush
Wedbush
$11$10
Buy
85.87%
Upside
Reiterated
11/10/25
MannKind's Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
Leerink Partners Analyst forecast on MNKD
Leerink Partners
Leerink Partners
$7$9
Buy
67.29%
Upside
Initiated
10/10/25
MannKind (MNKD) Receives a Buy from Leerink PartnersLeerink Partners analyst Faisal A. Khurshid resumes coverage on MannKind (NASDAQ: MNKD) with a Outperform rating and a price target of $9.00.
Mizuho Securities Analyst forecast on MNKD
Mizuho Securities
Mizuho Securities
$12$10
Buy
85.87%
Upside
Reiterated
08/07/25
Mizuho Securities Remains a Buy on MannKind (MNKD)
Cantor Fitzgerald Analyst forecast on MNKD
Cantor Fitzgerald
Cantor Fitzgerald
$9
Buy
67.29%
Upside
Reiterated
03/20/25
MannKind (MNKD) Gets a Buy from Cantor Fitzgerald
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MannKind

1 Month
xxx
Success Rate
3/7 ratings generated profit
43%
Average Return
+0.09%
initiated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of +0.09% per trade.
3 Months
xxx
Success Rate
6/13 ratings generated profit
46%
Average Return
+14.68%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of +14.68% per trade.
1 Year
Success Rate
3/6 ratings generated profit
50%
Average Return
+23.77%
reiterated a buy rating 19 days ago
Copying Andreas Argyrides's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +23.77% per trade.
2 Years
xxx
Success Rate
8/13 ratings generated profit
62%
Average Return
+48.22%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 61.54% of your transactions generating a profit, with an average return of +48.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MNKD Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
14
18
17
20
18
Buy
0
0
0
0
2
Hold
8
14
13
9
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
32
30
29
24
In the current month, MNKD has received 20 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MNKD average Analyst price target in the past 3 months is 9.21.
Each month's total comprises the sum of three months' worth of ratings.

MNKD Financial Forecast

MNKD Earnings Forecast

Next quarter’s earnings estimate for MNKD is $0.02 with a range of -$0.05 to $0.07. The previous quarter’s EPS was $0.03. MNKD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MNKD has Performed in-line its overall industry.
Next quarter’s earnings estimate for MNKD is $0.02 with a range of -$0.05 to $0.07. The previous quarter’s EPS was $0.03. MNKD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MNKD has Performed in-line its overall industry.

MNKD Sales Forecast

Next quarter’s sales forecast for MNKD is $98.58M with a range of $80.00M to $109.16M. The previous quarter’s sales results were $82.13M. MNKD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MNKD has Performed in-line its overall industry.
Next quarter’s sales forecast for MNKD is $98.58M with a range of $80.00M to $109.16M. The previous quarter’s sales results were $82.13M. MNKD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MNKD has Performed in-line its overall industry.

MNKD Stock Forecast FAQ

What is MNKD’s average 12-month price target, according to analysts?
Based on analyst ratings, Mannkind Corp.’s 12-month average price target is 9.21.
    What is MNKD’s upside potential, based on the analysts’ average price target?
    Mannkind Corp. has 71.19% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MNKD a Buy, Sell or Hold?
          Mannkind Corp. has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Mannkind Corp.’s price target?
            The average price target for Mannkind Corp. is 9.21. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $11.00 ,the lowest forecast is $7.50. The average price target represents 71.19% Increase from the current price of $5.38.
              What do analysts say about Mannkind Corp.?
              Mannkind Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of MNKD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis